ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 73735 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 73735; 2) Community: the network communities that were significantly associated with the response to NSC 73735; 3) Molecule: the relationships between components within communities and NSC 73735; 4) MDR: the compounds that were significantly associated with the NSC 73735.

NSC Compound Enrichment Correlation
NSC 137679 9H-Purine-6(1H)-one, 2-amino-9-.beta.-D-ribofuranosyl-6-seleno- 0.00286159651545682 0.36025209
NSC 253995 Europate(1-), tetrakis(4,4,4-trifluoro-1-phenyl-1,3-butanedionato-O,O')-, hydrogen, compd. with pyridine 0.00286159651545682 0.46266579
NSC 321237 Mercury, (4-aminophenyl)(6-thioguanosinato-N7,S6)- 0.00286159651545682 0.41442155
NSC 46598 Null 0.00286159651545682 0.48783334
NSC 49689 Null 0.00286159651545682 0.35359986
NSC 616348 Irinotecan hydrochloride 0.00286159651545682 0.51217831
NSC 618939 Camptothecin Derivative 0.00286159651545682 0.50708902
NSC 643001 3'O-phosphono-(Z)-combretastatin A-4, ammonium salt, hydrate [10:15:4] 0.00286159651545682 0.49347946
NSC 646381 Null 0.00286159651545682 0.50487793
NSC 646847 Bengamide G 0.00286159651545682 0.42440647
Total:140  Current:16    [First] [Prev] [Next] [Last]